CAH vs HSIC — Key Metrics

Metric CAH (CARDINAL HEALTH INC) HSIC (HENRY SCHEIN INC)
Price278.3285.69
Market Cap64.33 Billion9.47 Billion
P/E (TTM)35.8223.29
P/B (Quarterly)-20.4642.887
P/S (TTM)0.250.69
Net Profit Margin (TTM)0.73.1
Gross Margin (TTM)3.931.6
ROE (TTM)-62.613.1
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

CARDINAL HEALTH INC
vs
 
HENRY SCHEIN INC
 
CARDINAL HEALTH INC
vs
 
HENRY SCHEIN INC
Performance Comparison
AI Model Recommendation
CAH · CARDINAL HEALTH INC

Greatly Outperform

64
UnderperformOutperform
HSIC · HENRY SCHEIN INC

Greatly Outperform

61
UnderperformOutperform
Recommendation Summary

Both stocks are projected to significantly outperform the market over the next year. If you have to make a choice, Upfront Recommendation: CAH.

Financial Metrics
Prices delayed ~15 min
CAH Metrics HSIC
$278.32 Price $85.69
— Market Capitalization —
35.82 Price to Earnings Ratio 23.29
0.25 Price to Sales 0.69
13.0 Price to FCF Ratio 18.94
6.4 Price to Gross Profit 2.18
1.57 Price to Current Assets 1.98

CAH vs HSIC at a glance

Cardinal Health INC (CAH) and Henry Schein INC (HSIC) are both Medical Distribution companies in the Healthcare sector. CAH is the larger, at $64.3 billion in market value against $9.5 billion for HSIC, about 6.8 times the size.

On trailing-twelve-month figures, CAH trades at 35.8 times trailing earnings and HSIC at 23.3; net profit margins are 0.7% and 3.1%.

The Upfront Investment model currently rates both Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.